Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3268473 | 0.89 | MAOB (0.42) | KMT2AMAOBHPGDSMN1; SMN2LMNA | |
| SCHEMBL234222 | 0.86 | TDP1 (0.45) | KMT2AMEN1NPC1MAOBHPGD | |
| SCHEMBL2756025 | 0.83 | MAPK1 (0.43) | KMT2AMEN1NPC1MAOBHPGD | |
| SCHEMBL234126 | 0.80 | MAOB (0.47) | KMT2AMAOBHPGDSMN1; SMN2LMNA | |
| SCHEMBL1008532 | 0.79 | PTPN1 (0.48) | KMT2AMEN1MAOBHPGDSMN1; SMN2 | |
| SCHEMBL15300298 | 0.78 | MAOB (0.43) | KMT2AMEN1NPC1MAOBHPGD | |
| SCHEMBL1634331 | 0.78 | TDP1 (0.52) | KMT2AMEN1NPC1MAOBSMN1; SMN2 | |
| SCHEMBL1135054 | 0.78 | THRA (0.44) | KMT2AMAOBHPGDSMN1; SMN2LMNA | |
| SCHEMBL2090098 | 0.76 | ALDH1A1 (0.43) | KMT2AMAOBHPGDSMN1; SMN2LMNA | |
| SCHEMBL237424 | 0.76 | MAOB (0.48) | MAOBHPGDSMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004442-A1 | SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS | WELLSTAT THERAPEUTICS CORPORATION (US) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004442-A1 | SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS | PGD, HPD, MLYCD | KMT2A 2740/4885MEN1 3664/4885NPC1 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.